The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Embolotherapy Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Embolotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Embolotherapy market size is estimated to be worth US$ 3918 million in 2021 and is forecast to a readjusted size of USD 6168.7 million by 2028 with a CAGR of 6.7% during review period. Cancer accounting for % of the Embolotherapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Microspheres for Embolization segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Embolotherapy include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., and Johnson & Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Embolotherapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Microspheres for Embolization
Embolism Particles
Embolic coils
Liquid Embolic Agent
Auxiliary Embolization Material
Others
Market segment by Application, can be divided into
Cancer
Peripheral Aascular Disease
Nerve System Disease
Others
Market segment by players, this report covers
Medtronic
Boston Scientific
Terumo
Penumbra, Inc.
Johnson & Johnson
Sirtex
Merit Medical
Varian
Stryker
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Cook Medical
Kaneka
Meril Life Sciences
Peijia Medical Limited
Wallaby Medical
MicroPort Scientific Corporation
Shandong Visee Medical Devices Co.,Ltd
Beijing Taijie Weiye Technology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Embolotherapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Embolotherapy, with revenue, gross margin and global market share of Embolotherapy from 2019 to 2022.
Chapter 3, the Embolotherapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Embolotherapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Embolotherapy research findings and conclusion, appendix and data source.
Geographical Area
Global
The Embolotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Embolotherapy market size is estimated to be worth US$ 3918 million in 2021 and is forecast to a readjusted size of USD 6168.7 million by 2028 with a CAGR of 6.7% during review period. Cancer accounting for % of the Embolotherapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Microspheres for Embolization segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Embolotherapy include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., and Johnson & Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Embolotherapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Microspheres for Embolization
Embolism Particles
Embolic coils
Liquid Embolic Agent
Auxiliary Embolization Material
Others
Market segment by Application, can be divided into
Cancer
Peripheral Aascular Disease
Nerve System Disease
Others
Market segment by players, this report covers
Medtronic
Boston Scientific
Terumo
Penumbra, Inc.
Johnson & Johnson
Sirtex
Merit Medical
Varian
Stryker
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Cook Medical
Kaneka
Meril Life Sciences
Peijia Medical Limited
Wallaby Medical
MicroPort Scientific Corporation
Shandong Visee Medical Devices Co.,Ltd
Beijing Taijie Weiye Technology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Embolotherapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Embolotherapy, with revenue, gross margin and global market share of Embolotherapy from 2019 to 2022.
Chapter 3, the Embolotherapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Embolotherapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Embolotherapy research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Embolotherapy
1.2 Classification of Embolotherapy by Type
1.2.1 Overview: Global Embolotherapy Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Embolotherapy Revenue Market Share by Type in 2021
1.2.3 Microspheres for Embolization
1.2.4 Embolism Particles
1.2.5 Embolic coils
1.2.6 Liquid Embolic Agent
1.2.7 Auxiliary Embolization Material
1.2.8 Others
1.3 Global Embolotherapy Market by Application
1.3.1 Overview: Global Embolotherapy Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cancer
1.3.3 Peripheral Aascular Disease
1.3.4 Nerve System Disease
1.3.5 Others
1.4 Global Embolotherapy Market Size & Forecast
1.5 Global Embolotherapy Market Size and Forecast by Region
1.5.1 Global Embolotherapy Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Embolotherapy Market Size by Region, (2017-2022)
1.5.3 North America Embolotherapy Market Size and Prospect (2017-2028)
1.5.4 Europe Embolotherapy Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Embolotherapy Market Size and Prospect (2017-2028)
1.5.6 South America Embolotherapy Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Embolotherapy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Embolotherapy Market Drivers
1.6.2 Embolotherapy Market Restraints
1.6.3 Embolotherapy Trends Analysis
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Embolotherapy Product and Solutions
2.1.4 Medtronic Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Medtronic Recent Developments and Future Plans
2.2 Boston Scientific
2.2.1 Boston Scientific Details
2.2.2 Boston Scientific Major Business
2.2.3 Boston Scientific Embolotherapy Product and Solutions
2.2.4 Boston Scientific Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Boston Scientific Recent Developments and Future Plans
2.3 Terumo
2.3.1 Terumo Details
2.3.2 Terumo Major Business
2.3.3 Terumo Embolotherapy Product and Solutions
2.3.4 Terumo Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Terumo Recent Developments and Future Plans
2.4 Penumbra, Inc.
2.4.1 Penumbra, Inc. Details
2.4.2 Penumbra, Inc. Major Business
2.4.3 Penumbra, Inc. Embolotherapy Product and Solutions
2.4.4 Penumbra, Inc. Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Penumbra, Inc. Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Embolotherapy Product and Solutions
2.5.4 Johnson & Johnson Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 Sirtex
2.6.1 Sirtex Details
2.6.2 Sirtex Major Business
2.6.3 Sirtex Embolotherapy Product and Solutions
2.6.4 Sirtex Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Sirtex Recent Developments and Future Plans
2.7 Merit Medical
2.7.1 Merit Medical Details
2.7.2 Merit Medical Major Business
2.7.3 Merit Medical Embolotherapy Product and Solutions
2.7.4 Merit Medical Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Merit Medical Recent Developments and Future Plans
2.8 Varian
2.8.1 Varian Details
2.8.2 Varian Major Business
2.8.3 Varian Embolotherapy Product and Solutions
2.8.4 Varian Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Varian Recent Developments and Future Plans
2.9 Stryker
2.9.1 Stryker Details
2.9.2 Stryker Major Business
2.9.3 Stryker Embolotherapy Product and Solutions
2.9.4 Stryker Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Stryker Recent Developments and Future Plans
2.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd
2.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Details
2.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
2.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product and Solutions
2.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments and Future Plans
2.11 Cook Medical
2.11.1 Cook Medical Details
2.11.2 Cook Medical Major Business
2.11.3 Cook Medical Embolotherapy Product and Solutions
2.11.4 Cook Medical Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Cook Medical Recent Developments and Future Plans
2.12 Kaneka
2.12.1 Kaneka Details
2.12.2 Kaneka Major Business
2.12.3 Kaneka Embolotherapy Product and Solutions
2.12.4 Kaneka Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Kaneka Recent Developments and Future Plans
2.13 Meril Life Sciences
2.13.1 Meril Life Sciences Details
2.13.2 Meril Life Sciences Major Business
2.13.3 Meril Life Sciences Embolotherapy Product and Solutions
2.13.4 Meril Life Sciences Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Meril Life Sciences Recent Developments and Future Plans
2.14 Peijia Medical Limited
2.14.1 Peijia Medical Limited Details
2.14.2 Peijia Medical Limited Major Business
2.14.3 Peijia Medical Limited Embolotherapy Product and Solutions
2.14.4 Peijia Medical Limited Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Peijia Medical Limited Recent Developments and Future Plans
2.15 Wallaby Medical
2.15.1 Wallaby Medical Details
2.15.2 Wallaby Medical Major Business
2.15.3 Wallaby Medical Embolotherapy Product and Solutions
2.15.4 Wallaby Medical Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Wallaby Medical Recent Developments and Future Plans
2.16 MicroPort Scientific Corporation
2.16.1 MicroPort Scientific Corporation Details
2.16.2 MicroPort Scientific Corporation Major Business
2.16.3 MicroPort Scientific Corporation Embolotherapy Product and Solutions
2.16.4 MicroPort Scientific Corporation Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 MicroPort Scientific Corporation Recent Developments and Future Plans
2.17 Shandong Visee Medical Devices Co.,Ltd
2.17.1 Shandong Visee Medical Devices Co.,Ltd Details
2.17.2 Shandong Visee Medical Devices Co.,Ltd Major Business
2.17.3 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product and Solutions
2.17.4 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Developments and Future Plans
2.18 Beijing Taijie Weiye Technology
2.18.1 Beijing Taijie Weiye Technology Details
2.18.2 Beijing Taijie Weiye Technology Major Business
2.18.3 Beijing Taijie Weiye Technology Embolotherapy Product and Solutions
2.18.4 Beijing Taijie Weiye Technology Embolotherapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Beijing Taijie Weiye Technology Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Embolotherapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Embolotherapy Players Market Share in 2021
3.2.2 Top 10 Embolotherapy Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Embolotherapy Players Head Office, Products and Services Provided
3.4 Embolotherapy Mergers & Acquisitions
3.5 Embolotherapy New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Embolotherapy Revenue and Market Share by Type (2017-2022)
4.2 Global Embolotherapy Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Embolotherapy Revenue Market Share by Application (2017-2022)
5.2 Global Embolotherapy Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Embolotherapy Revenue by Type (2017-2028)
6.2 North America Embolotherapy Revenue by Application (2017-2028)
6.3 North America Embolotherapy Market Size by Country
6.3.1 North America Embolotherapy Revenue by Country (2017-2028)
6.3.2 United States Embolotherapy Market Size and Forecast (2017-2028)
6.3.3 Canada Embolotherapy Market Size and Forecast (2017-2028)
6.3.4 Mexico Embolotherapy Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Embolotherapy Revenue by Type (2017-2028)
7.2 Europe Embolotherapy Revenue by Application (2017-2028)
7.3 Europe Embolotherapy Market Size by Country
7.3.1 Europe Embolotherapy Revenue by Country (2017-2028)
7.3.2 Germany Embolotherapy Market Size and Forecast (2017-2028)
7.3.3 France Embolotherapy Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Embolotherapy Market Size and Forecast (2017-2028)
7.3.5 Russia Embolotherapy Market Size and Forecast (2017-2028)
7.3.6 Italy Embolotherapy Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Embolotherapy Revenue by Type (2017-2028)
8.2 Asia-Pacific Embolotherapy Revenue by Application (2017-2028)
8.3 Asia-Pacific Embolotherapy Market Size by Region
8.3.1 Asia-Pacific Embolotherapy Revenue by Region (2017-2028)
8.3.2 China Embolotherapy Market Size and Forecast (2017-2028)
8.3.3 Japan Embolotherapy Market Size and Forecast (2017-2028)
8.3.4 South Korea Embolotherapy Market Size and Forecast (2017-2028)
8.3.5 India Embolotherapy Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Embolotherapy Market Size and Forecast (2017-2028)
8.3.7 Australia Embolotherapy Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Embolotherapy Revenue by Type (2017-2028)
9.2 South America Embolotherapy Revenue by Application (2017-2028)
9.3 South America Embolotherapy Market Size by Country
9.3.1 South America Embolotherapy Revenue by Country (2017-2028)
9.3.2 Brazil Embolotherapy Market Size and Forecast (2017-2028)
9.3.3 Argentina Embolotherapy Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Embolotherapy Revenue by Type (2017-2028)
10.2 Middle East & Africa Embolotherapy Revenue by Application (2017-2028)
10.3 Middle East & Africa Embolotherapy Market Size by Country
10.3.1 Middle East & Africa Embolotherapy Revenue by Country (2017-2028)
10.3.2 Turkey Embolotherapy Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Embolotherapy Market Size and Forecast (2017-2028)
10.3.4 UAE Embolotherapy Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Embolotherapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Embolotherapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Embolotherapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Embolotherapy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Embolotherapy Revenue Market Share by Region (2023-2028)
Table 6. Medtronic Corporate Information, Head Office, and Major Competitors
Table 7. Medtronic Major Business
Table 8. Medtronic Embolotherapy Product and Solutions
Table 9. Medtronic Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Boston Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Boston Scientific Major Business
Table 12. Boston Scientific Embolotherapy Product and Solutions
Table 13. Boston Scientific Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Terumo Corporate Information, Head Office, and Major Competitors
Table 15. Terumo Major Business
Table 16. Terumo Embolotherapy Product and Solutions
Table 17. Terumo Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Penumbra, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Penumbra, Inc. Major Business
Table 20. Penumbra, Inc. Embolotherapy Product and Solutions
Table 21. Penumbra, Inc. Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 23. Johnson & Johnson Major Business
Table 24. Johnson & Johnson Embolotherapy Product and Solutions
Table 25. Johnson & Johnson Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Sirtex Corporate Information, Head Office, and Major Competitors
Table 27. Sirtex Major Business
Table 28. Sirtex Embolotherapy Product and Solutions
Table 29. Sirtex Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Merit Medical Corporate Information, Head Office, and Major Competitors
Table 31. Merit Medical Major Business
Table 32. Merit Medical Embolotherapy Product and Solutions
Table 33. Merit Medical Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Varian Corporate Information, Head Office, and Major Competitors
Table 35. Varian Major Business
Table 36. Varian Embolotherapy Product and Solutions
Table 37. Varian Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Stryker Corporate Information, Head Office, and Major Competitors
Table 39. Stryker Major Business
Table 40. Stryker Embolotherapy Product and Solutions
Table 41. Stryker Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Jiangsu Hengrui Pharmaceuticals Co., Ltd Corporate Information, Head Office, and Major Competitors
Table 43. Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
Table 44. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product and Solutions
Table 45. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Cook Medical Corporate Information, Head Office, and Major Competitors
Table 47. Cook Medical Major Business
Table 48. Cook Medical Embolotherapy Product and Solutions
Table 49. Cook Medical Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Kaneka Corporate Information, Head Office, and Major Competitors
Table 51. Kaneka Major Business
Table 52. Kaneka Embolotherapy Product and Solutions
Table 53. Kaneka Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Meril Life Sciences Corporate Information, Head Office, and Major Competitors
Table 55. Meril Life Sciences Major Business
Table 56. Meril Life Sciences Embolotherapy Product and Solutions
Table 57. Meril Life Sciences Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Peijia Medical Limited Corporate Information, Head Office, and Major Competitors
Table 59. Peijia Medical Limited Major Business
Table 60. Peijia Medical Limited Embolotherapy Product and Solutions
Table 61. Peijia Medical Limited Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Wallaby Medical Corporate Information, Head Office, and Major Competitors
Table 63. Wallaby Medical Major Business
Table 64. Wallaby Medical Embolotherapy Product and Solutions
Table 65. Wallaby Medical Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. MicroPort Scientific Corporation Corporate Information, Head Office, and Major Competitors
Table 67. MicroPort Scientific Corporation Major Business
Table 68. MicroPort Scientific Corporation Embolotherapy Product and Solutions
Table 69. MicroPort Scientific Corporation Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Shandong Visee Medical Devices Co.,Ltd Corporate Information, Head Office, and Major Competitors
Table 71. Shandong Visee Medical Devices Co.,Ltd Major Business
Table 72. Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product and Solutions
Table 73. Shandong Visee Medical Devices Co.,Ltd Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Beijing Taijie Weiye Technology Corporate Information, Head Office, and Major Competitors
Table 75. Beijing Taijie Weiye Technology Major Business
Table 76. Beijing Taijie Weiye Technology Embolotherapy Product and Solutions
Table 77. Beijing Taijie Weiye Technology Embolotherapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Global Embolotherapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 79. Global Embolotherapy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 80. Breakdown of Embolotherapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 81. Embolotherapy Players Head Office, Products and Services Provided
Table 82. Embolotherapy Mergers & Acquisitions in the Past Five Years
Table 83. Embolotherapy New Entrants and Expansion Plans
Table 84. Global Embolotherapy Revenue (USD Million) by Type (2017-2022)
Table 85. Global Embolotherapy Revenue Share by Type (2017-2022)
Table 86. Global Embolotherapy Revenue Forecast by Type (2023-2028)
Table 87. Global Embolotherapy Revenue by Application (2017-2022)
Table 88. Global Embolotherapy Revenue Forecast by Application (2023-2028)
Table 89. North America Embolotherapy Revenue by Type (2017-2022) & (USD Million)
Table 90. North America Embolotherapy Revenue by Type (2023-2028) & (USD Million)
Table 91. North America Embolotherapy Revenue by Application (2017-2022) & (USD Million)
Table 92. North America Embolotherapy Revenue by Application (2023-2028) & (USD Million)
Table 93. North America Embolotherapy Revenue by Country (2017-2022) & (USD Million)
Table 94. North America Embolotherapy Revenue by Country (2023-2028) & (USD Million)
Table 95. Europe Embolotherapy Revenue by Type (2017-2022) & (USD Million)
Table 96. Europe Embolotherapy Revenue by Type (2023-2028) & (USD Million)
Table 97. Europe Embolotherapy Revenue by Application (2017-2022) & (USD Million)
Table 98. Europe Embolotherapy Revenue by Application (2023-2028) & (USD Million)
Table 99. Europe Embolotherapy Revenue by Country (2017-2022) & (USD Million)
Table 100. Europe Embolotherapy Revenue by Country (2023-2028) & (USD Million)
Table 101. Asia-Pacific Embolotherapy Revenue by Type (2017-2022) & (USD Million)
Table 102. Asia-Pacific Embolotherapy Revenue by Type (2023-2028) & (USD Million)
Table 103. Asia-Pacific Embolotherapy Revenue by Application (2017-2022) & (USD Million)
Table 104. Asia-Pacific Embolotherapy Revenue by Application (2023-2028) & (USD Million)
Table 105. Asia-Pacific Embolotherapy Revenue by Region (2017-2022) & (USD Million)
Table 106. Asia-Pacific Embolotherapy Revenue by Region (2023-2028) & (USD Million)
Table 107. South America Embolotherapy Revenue by Type (2017-2022) & (USD Million)
Table 108. South America Embolotherapy Revenue by Type (2023-2028) & (USD Million)
Table 109. South America Embolotherapy Revenue by Application (2017-2022) & (USD Million)
Table 110. South America Embolotherapy Revenue by Application (2023-2028) & (USD Million)
Table 111. South America Embolotherapy Revenue by Country (2017-2022) & (USD Million)
Table 112. South America Embolotherapy Revenue by Country (2023-2028) & (USD Million)
Table 113. Middle East & Africa Embolotherapy Revenue by Type (2017-2022) & (USD Million)
Table 114. Middle East & Africa Embolotherapy Revenue by Type (2023-2028) & (USD Million)
Table 115. Middle East & Africa Embolotherapy Revenue by Application (2017-2022) & (USD Million)
Table 116. Middle East & Africa Embolotherapy Revenue by Application (2023-2028) & (USD Million)
Table 117. Middle East & Africa Embolotherapy Revenue by Country (2017-2022) & (USD Million)
Table 118. Middle East & Africa Embolotherapy Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Embolotherapy Picture
Figure 2. Global Embolotherapy Revenue Market Share by Type in 2021
Figure 3. Microspheres for Embolization
Figure 4. Embolism Particles
Figure 5. Embolic coils
Figure 6. Liquid Embolic Agent
Figure 7. Auxiliary Embolization Material
Figure 8. Others
Figure 9. Embolotherapy Revenue Market Share by Application in 2021
Figure 10. Cancer Picture
Figure 11. Peripheral Aascular Disease Picture
Figure 12. Nerve System Disease Picture
Figure 13. Others Picture
Figure 14. Global Embolotherapy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global Embolotherapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Embolotherapy Revenue Market Share by Region (2017-2028)
Figure 17. Global Embolotherapy Revenue Market Share by Region in 2021
Figure 18. North America Embolotherapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe Embolotherapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific Embolotherapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America Embolotherapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa Embolotherapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Embolotherapy Market Drivers
Figure 24. Embolotherapy Market Restraints
Figure 25. Embolotherapy Market Trends
Figure 26. Medtronic Recent Developments and Future Plans
Figure 27. Boston Scientific Recent Developments and Future Plans
Figure 28. Terumo Recent Developments and Future Plans
Figure 29. Penumbra, Inc. Recent Developments and Future Plans
Figure 30. Johnson & Johnson Recent Developments and Future Plans
Figure 31. Sirtex Recent Developments and Future Plans
Figure 32. Merit Medical Recent Developments and Future Plans
Figure 33. Varian Recent Developments and Future Plans
Figure 34. Stryker Recent Developments and Future Plans
Figure 35. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments and Future Plans
Figure 36. Cook Medical Recent Developments and Future Plans
Figure 37. Kaneka Recent Developments and Future Plans
Figure 38. Meril Life Sciences Recent Developments and Future Plans
Figure 39. Peijia Medical Limited Recent Developments and Future Plans
Figure 40. Wallaby Medical Recent Developments and Future Plans
Figure 41. MicroPort Scientific Corporation Recent Developments and Future Plans
Figure 42. Shandong Visee Medical Devices Co.,Ltd Recent Developments and Future Plans
Figure 43. Beijing Taijie Weiye Technology Recent Developments and Future Plans
Figure 44. Global Embolotherapy Revenue Share by Players in 2021
Figure 45. Embolotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 46. Global Top 3 Players Embolotherapy Revenue Market Share in 2021
Figure 47. Global Top 10 Players Embolotherapy Revenue Market Share in 2021
Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 49. Global Embolotherapy Revenue Share by Type in 2021
Figure 50. Global Embolotherapy Market Share Forecast by Type (2023-2028)
Figure 51. Global Embolotherapy Revenue Share by Application in 2021
Figure 52. Global Embolotherapy Market Share Forecast by Application (2023-2028)
Figure 53. North America Embolotherapy Sales Market Share by Type (2017-2028)
Figure 54. North America Embolotherapy Sales Market Share by Application (2017-2028)
Figure 55. North America Embolotherapy Revenue Market Share by Country (2017-2028)
Figure 56. United States Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Canada Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Mexico Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Europe Embolotherapy Sales Market Share by Type (2017-2028)
Figure 60. Europe Embolotherapy Sales Market Share by Application (2017-2028)
Figure 61. Europe Embolotherapy Revenue Market Share by Country (2017-2028)
Figure 62. Germany Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. France Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. United Kingdom Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Russia Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Italy Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Asia-Pacific Embolotherapy Sales Market Share by Type (2017-2028)
Figure 68. Asia-Pacific Embolotherapy Sales Market Share by Application (2017-2028)
Figure 69. Asia-Pacific Embolotherapy Revenue Market Share by Region (2017-2028)
Figure 70. China Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Japan Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South Korea Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. India Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Southeast Asia Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Australia Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South America Embolotherapy Sales Market Share by Type (2017-2028)
Figure 77. South America Embolotherapy Sales Market Share by Application (2017-2028)
Figure 78. South America Embolotherapy Revenue Market Share by Country (2017-2028)
Figure 79. Brazil Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Argentina Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Middle East and Africa Embolotherapy Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Embolotherapy Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Embolotherapy Revenue Market Share by Country (2017-2028)
Figure 84. Turkey Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Saudi Arabia Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. UAE Embolotherapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. Methodology
Figure 88. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
